Pharmacology, Toxicology and Pharmaceutical Science
Inulin
100%
Mouse
65%
Influenza Vaccine
62%
Tablet
56%
Vaccination Policy
56%
Powder Formulation
49%
Trehalose
46%
Microsphere
36%
Subunit Vaccine
35%
Sustained Release
29%
Live Attenuated Influenza Vaccine
29%
Excipient
28%
Influenza Virus
24%
Dosage Forms
23%
Carbohydrates
22%
Adjuvant
22%
Oligosaccharide
22%
Diazepam
21%
Platelet Derived Growth Factor Receptor
20%
Implant
20%
Antivirus Agent
20%
Pullulan
20%
Alkaline Phosphatase
19%
Inactivated Virus Vaccine
18%
Copolymer
18%
Bioavailability
17%
Povidone
16%
Drug Delivery System
15%
Buffer
15%
Immunogenicity
14%
Dextran
14%
Virus Infection
14%
Macrogol
13%
Influenza A Virus (H5N1)
13%
Mannitol
13%
Route of Administration
13%
Nanoparticle
12%
Immunoglobulin A
12%
Human Respiratory Syncytial Virus
12%
Infrared Spectroscopy
12%
Curcumin
12%
Polycaprolactone
11%
Infection
11%
Fenofibrate
11%
Bovine Serum Albumin
10%
Liquid Formulation
10%
Respiratory Tract
10%
Cuprophane
10%
Pharmacokinetics
10%
Drug Carrier
9%
Immunology and Microbiology
Influenza
40%
Influenza Vaccine
35%
Vaccine Efficacy
33%
Lung Slice
20%
Mouse
20%
Adjuvant
19%
Subunit Vaccine
18%
Vaccination Policy
16%
Influenza A Virus (H5N1)
14%
Immune Response
13%
Dry Powder
12%
Powder
12%
Freeze Drying
12%
Inactivated Virus Vaccine
10%
T Cell
10%
Cell Proliferation
8%
Immunogenicity
8%
Influenza Virus
8%
Enhancer Region
8%
Heat Shock
8%
Cell Death
8%
Titer
7%
Virus Inactivation
7%
Fibrogenesis
6%
Immunoglobulin A
6%
Peripheral Blood Mononuclear Cell
6%
RNA Interference
5%
Tissue Slice
5%
Freeze Thawing
5%
Phosphoryl Lipid A
5%
Immunostimulation
5%
Viral Entry
5%
Keyphrases
Inulin
20%
Sugar Glass
14%
Influenza
13%
Precision-cut Lung Slices
12%
Lung
12%
Influenza Vaccine
12%
Subunit Vaccine
9%
Platelet-derived Growth Factor Receptor (PDGFR)
8%
Alkaline Phosphatase
8%
Extrusion Temperature
8%
Pulmonary Delivery
8%
Cell Death
8%
Pulmonary Route
7%
Pulmonary Vaccination
7%
Antibody Response
7%
Hot-melt Extrusion
7%
Trehalose
7%
Whole-cell Vaccine
6%
Spray Freeze Drying
6%
Immunogenicity
6%
Stabilizer
6%
Fibrosis
6%
Sustained Release
6%
Antifibrotic
6%
Fibrogenesis
6%
Multiblock Copolymer
6%
Lung Slice
5%
Idiopathic Pulmonary Fibrosis
5%
T Cells
5%
Vaccine Formulation
5%
Inhalation
5%
Virus
5%
Cell Proliferation
5%
Dry Formulation
5%
Pulmonary Administration
5%
Polycaprolactone
5%
Oligosaccharides
5%
Liquid Formulation
5%